Chronic News and Research

RSS

Italy's economically disadvantaged people have higher rates of hospitalization for ACSC disorders

Despite free public healthcare, Italy's poor are more likely to end up in hospital with avoidable conditions, new research shows. This pattern, reported today in the online open access journal BMC Public Health, mirrors findings from a number of different healthcare systems around the world, although to date fewer studies have been completed in Europe.

11 Dec 2009

Tasigna demonstrates greater efficacy over Gleevec in chronic Ph+ CML patients

In a large Phase III clinical trial, Tasigna (nilotinib capsules) demonstrated greater efficacy over Gleevec (imatinib) in the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. The new clinical data were just presented as a late breaking abstract at the 51st annual meeting of the American Society of Hematology (ASH), in New Orleans, Louisiana.

11 Dec 2009

NIH launches a $37 million program to reduce obesity

The National Institutes of Health is launching a $37 million program that will use findings from basic research on human behavior to develop more effective interventions to reduce obesity.

11 Dec 2009

BioWorld highlights the development of 97 drugs and vaccines to treat HIV/AIDS

BioWorld Today recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America (PhRMA) that identifies 97 new drugs and vaccines in development to treat or prevent HIV/AIDS and related conditions.

11 Dec 2009

Carotid endarterectomy can benefit patients with chronic kidney disease

Physicians should be comfortable referring some patients with chronic kidney disease (CKD) for effective stroke prevention surgery, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The findings indicate that CKD patients gain a significant benefit from the procedures without an increased risk of dying from surgical complications.

11 Dec 2009

FDA Drugs Advisory Committee recommends approval for Gilead Sciences' aztreonam for inhalation solution

Gilead Sciences, Inc. today announced that the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has recommended that aztreonam for inhalation solution be approved for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF).

11 Dec 2009

FY2010 State and Foreign Ops bill expected to move on the Hill this month

The fiscal year 2010 State and Foreign Operations Appropriations bill, which includes funding for global health-related measures, "is moving on the Hill as part of a mammoth catch-all spending bill that's expected to move through both chambers this month," Foreign Policy's blog, "The Cable," reports. "

10 Dec 2009

InNexus Biotechnology, XERIS Pharmaceuticals collaborate in development of novel antibody delivery system

InNexus Biotechnology Inc. and XERIS Pharmaceuticals, Inc. announced today a research collaboration in which the companies will pursue development of a potential subcutaneous delivery of InNexus’ Dynamic Cross Linking (DXL™) antibodies using XERIS’ proprietary formulation-injection technologies.

10 Dec 2009

Phytel’s Proactive Patient Outreach solution to be implemented at The Iowa Clinic

Phytel, the leader in empowering physicians to drive health improvement through technology, announced today that The Iowa Clinic, a large multispecialty group based in Des Moines, has agreed to implement Phytel’s Proactive Patient Outreach solution to make sure that all of its patients receive appropriate preventive and chronic disease care.

10 Dec 2009

HSA survey reveals drug cost inflation in workers’ compensation is up by 7.5%

Drug cost inflation in workers’ compensation is up 7.5 percent according to Health Strategy Associates’ (HSA) Sixth Annual Survey of Prescription Drug Management in Workers’ Compensation.

10 Dec 2009

Knowledge gaps exist among physicians in diagnosis and management of food allergy

With an estimated four to six percent of children in the U.S. suffering from food allergies, a new study shows that pediatricians and family physicians aren't always confident they have the ability to diagnose or treat food allergies.

10 Dec 2009

Rituxan improves patients with previously untreated CLL, shows Phase III study CLL8

Roche announced today at the 51st Meeting of the American Society of Hematology (ASH) in New Orleans, LA (USA) that the pivotal Phase III study CLL8 showed that patients with previously-untreated chronic lymphocytic leukemia (CLL) survived their disease longer when treated with Rituxan (rituximab) compared to chemotherapy alone.

10 Dec 2009

Dermal stem cells may be useful for treating diabetic ulcers and neurological disorders

Scientists have discovered a new type of stem cell in the skin that acts surprisingly like certain stem cells found in embryos: both can generate fat, bone, cartilage, and even nerve cells.

10 Dec 2009

Study reveals increased discussion on flu vaccines has no significant impact on public's behavior

Seasonal flu vaccination rates among American adults have only slightly improved over last year, despite increased public discussion of the importance of influenza vaccines resulting from the worldwide outbreak of the H1N1 virus.

10 Dec 2009

Second pivotal Phase 3 trial to evaluate investigational Lp-PLA2 inhibitor darapladib initiated

Attached is a press release issued earlier this morning by GlaxoSmithKline, announcing that GSK has initiated its second pivotal Phase 3 trial to evaluate the efficacy of long-term treatment with the investigational Lp-PLA2 inhibitor darapladib in men and women with acute coronary syndrome (ACS).

10 Dec 2009

Rise in U.S. disability health care spending, but preventive care may reduce expenditure

Just over one-quarter of U.S. adult health care spending was associated with disability in 2006, according to a new study by researchers at RTI International and the U.S. Centers for Disease Control & Prevention.

10 Dec 2009

OPDQ adopts global vision on food and nutrition

The Ordre professionnel des diététistes du Québec (OPDQ) believes it is time to reflect on the future of the profession. The OPDQ has therefore initiated a wide-scale consultation process, first with its own members and later with partners and stakeholders in various food-related and nutrition-related sectors. The results of this process will ultimately be the topic of discussions during an interdisciplinary summit to be held next March.

9 Dec 2009

Clinical trial results demonstrate greater efficacy of nilotinib over imatinib for Ph+ CML

In a large clinical trial, nilotinib demonstrated greater efficacy over the current gold standard treatment, imatinib, in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML) in the chronic phase.

9 Dec 2009

Save Flexible Spending Plans praises Sen. Charles E. Schumer for filing FSA protection amendment

Save Flexible Spending Plans, a national grassroots organization dedicated to protecting flexible spending accounts (FSAs), praised Sen. Charles E. Schumer (D-NY) for filing an amendment to the Patient Protection and Affordable Care Act that would help protect the future use and value of FSAs.

9 Dec 2009

March of Dimes poll finds majority of pregnant women worry about birth defects

The March of Dimes polled about 1,200 moms to find out exactly what it is that caused them to lose sleep (other than the fact they were pregnant!) while they were pregnant. The results were presented today at the March of Dimes National Communications Advisory Council luncheon where experienced, practicing obstetricians and gynecologists discussed the survey results, as well as some of the frequently asked questions their patients ask.

9 Dec 2009

Chronic News and Research

Italy's economically disadvantaged people have higher rates of hospitalization for ACSC disorders

Tasigna demonstrates greater efficacy over Gleevec in chronic Ph+ CML patients

NIH launches a $37 million program to reduce obesity

BioWorld highlights the development of 97 drugs and vaccines to treat HIV/AIDS

Carotid endarterectomy can benefit patients with chronic kidney disease

FDA Drugs Advisory Committee recommends approval for Gilead Sciences' aztreonam for inhalation solution

FY2010 State and Foreign Ops bill expected to move on the Hill this month

InNexus Biotechnology, XERIS Pharmaceuticals collaborate in development of novel antibody delivery system

Phytel’s Proactive Patient Outreach solution to be implemented at The Iowa Clinic

HSA survey reveals drug cost inflation in workers’ compensation is up by 7.5%

Knowledge gaps exist among physicians in diagnosis and management of food allergy

Rituxan improves patients with previously untreated CLL, shows Phase III study CLL8

Dermal stem cells may be useful for treating diabetic ulcers and neurological disorders

Study reveals increased discussion on flu vaccines has no significant impact on public's behavior

Second pivotal Phase 3 trial to evaluate investigational Lp-PLA2 inhibitor darapladib initiated

Rise in U.S. disability health care spending, but preventive care may reduce expenditure

OPDQ adopts global vision on food and nutrition

Clinical trial results demonstrate greater efficacy of nilotinib over imatinib for Ph+ CML

Save Flexible Spending Plans praises Sen. Charles E. Schumer for filing FSA protection amendment

March of Dimes poll finds majority of pregnant women worry about birth defects

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News